HSA-2023-0012-V112

Type II variation for application HSA-2023-0012. Type II variation: Facility Change for Sacubitrivex — minor update

Variation Number
HSA-2023-0012-V112
Type
Type II
Application
HSA-2023-0012
Change
CHG-2021-0112
Status
Pending
Fee
€69,740
Submitted
2024-02-08
Approved
—
Description

Type II variation: Facility Change for Sacubitrivex — minor update